Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
XM-001 by Hefei Starry Gene Biotechnology for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
XM-001 is under clinical development by Hefei Starry Gene Biotechnology and currently in Phase I for Wet (Neovascular / Exudative)...